Market Cap 10.74B
Revenue (ttm) 1.67B
Net Income (ttm) 356.98M
EPS (ttm) N/A
PE Ratio 26.04
Forward PE N/A
Profit Margin 21.39%
Debt to Equity Ratio 0.35
Volume 600
Avg Vol 428
Day's Range N/A - N/A
Shares Out 282.27M
Stochastic %K 36%
Beta 0.09
Analysts Sell
Price Target N/A

Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Far...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 358 10 4261
Address:
Orionintie 1A, Espo, Finland
Latest News on ORINY
No data available.